The costs of epilepsy and cost-based evaluations of anticonvulsants

Medicine & Life Sciences

• Anticonvulsants 75%
• Epilepsy 67%
• Costs and Cost Analysis 49%
• Cost Savings 11%
• Expert Testimony 10%
• Information Storage and Retrieval 9%
• Health Personnel 8%
• Cost-Benefit Analysis 8%
• Organizations 8%
• Research Personnel 6%
• Pharmaceutical Preparations 4%
• Therapeutics 1%

Social Sciences

• epilepsy 100%
• costs 44%
• evaluation 36%
• cost minimizing 14%
• expert opinions 10%
• savings 8%
• Healthcare 6%
• drug 6%
• well-being 5%
• interpretation 5%
• trend 4%